DTx East 2022: Catalysing the Digital Evolution of Healthcare

What:

In-Person Event

Why:

Digital therapeutics (DTx) are at a turning point. COVID-19 exposed a fragile healthcare system and tested the healthcare industry’s fortitude and resilience. Gaps were discovered, forcing the industry to adopt digital therapeutics to improve healthcare and make it more accessible.

Providers value digital therapeutics for improving disease management and treatment and expanding access to care. Payers value digital therapeutics for reducing the overall cost of care and improving member experience. Digital health business leaders value digital therapeutics for creating new business opportunities. These opportunities include digital-only solutions, digital therapies combined with medication therapies to improve drug effectiveness, and connected delivery devices such as auto-injectors or smart inhalers. Unlocking the full potential of digital therapeutics requires the industry to navigate challenges in reimbursement, regulation, physical adoption, patient engagement, and more.

SoftServe can help you identify new opportunities in your digital strategy and operations. Join us in Boston this September for DTx East to discover innovative solutions using artificial intelligence, machine learning, big data, and cloud. Meet with one of our industry specialists to discover how you can leverage these technologies to innovate at scale, reduce costs, and increase efficiency.